Mangoceuticals Inc. (MGRX)
MGRX trades on Nasdaq in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3716
-3.08% on the day
Market cap
$8.3M
Nano cap
Revenue · 2025
$456K
-26.0% on 2024
Net income · 2025
-$20.6M
-4526.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | MGRX on Nasdaq |
| Sector | Health Care |
| Industry | Misc Health and Biotechnology Services |
| Country | United States |
| IPO year | 2023 |
| SEC CIK | 0001938046 |
| SEC industry code | Services-Misc Health & Allied Services, NEC |
| Incorporated in | TX |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $456K |
| Net income | -$20.6M |
| Operating income | -$18.0M |
| Net margin | -4526.8% |
| Operating margin | -3954.3% |
| Revenue growth | -26.0% |
| Cash | $1.5M |
| Total assets | $16.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 18.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-10-09 |
| Latest annual report | 10-K | 2026-04-01 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-09 |
| Latest proxy | DEF 14A | 2025-02-18 |
Source: SEC EDGAR submissions feed, 240 recent filings. All filings on EDGAR.
Peers in Misc Health and Biotechnology Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CCEL | Cryo-Cell International Inc. | $4.30 | -4.44% | $34.7M |
| NIVF | NewGenIvf Group Limited | $0.1954 | -17.24% | $1.7M |
| PARK | Park Dental Partners Inc. | $19.59 | -3.31% | $93.2M |
| VMD | Viemed Healthcare Inc. Common Shares | $9.61 | +0.10% | $366.0M |
| AGL | agilon health inc. | $85.90 | +0.48% | $1.4B |
| PGNY | Progyny Inc. | $27.39 | -2.28% | $2.1B |
| SHC | Sotera Health Company | $18.21 | +0.33% | $5.2B |
| DVA | DaVita Inc. | $182.08 | +0.17% | $11.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier